Related Experiment Video
Updated: May 14, 2026
12:02
Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
Published on: June 6, 2017
HNRNPU mutations redirect cell cycle control to E2F in MYC-driven lymphomas.
Quratulain Qureshi1,2, Krysta Mila Coyle1,2, Callum Brown1,2
1Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, BC, Canada.
Blood Advances
|May 13, 2026
Summary
Mutations in the HNRNPU gene act as a tumor suppressor in B-cell lymphomas. Loss of HNRNPU function alters gene expression, promoting cell cycle progression and increasing sensitivity to E2F inhibitors.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- hnRNPU is a DNA/RNA binding protein crucial for RNA metabolism.
- Heterozygous HNRNPU mutations are found in B-cell lymphomas, but their function is unclear.
Purpose of the Study:
- Investigate the functional impact of HNRNPU mutations in B-cell lymphomas.
- Determine the therapeutic potential of targeting HNRNPU-mutated lymphomas.
Main Methods:
- Genome-wide and exome-wide sequencing meta-analysis.
- Isogenic cell line models.
- Analysis of gene expression and splicing alterations.
Main Results:
- HNRNPU mutations are more frequent in MYC-rearranged lymphomas (e.g., high-grade B-cell lymphoma, Burkitt lymphoma).
- HNRNPU acts as a haploinsufficient tumor suppressor, promoting cell cycle entry via altered gene expression and splicing.
- Reduced hnRNPU lowers MYC levels and enhances E2F signaling, creating a pro-proliferative state.
Conclusions:
- HNRNPU inactivation promotes MYC-driven lymphoma proliferation by altering MYC/E2F signaling.
- HNRNPU-mutated lymphomas exhibit increased dependence on E2F, suggesting sensitivity to E2F inhibitors.
- Targeting hnRNPU-mediated regulation of MYC offers a potential therapeutic strategy for lymphomas.
Related Concept Videos
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
02:38Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
01:23Negative Regulator Molecules
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
01:06Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Somatic cells are...
02:34Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
02:15M-Cdk Drives Transition Into Mitosis
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...